A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia | MicrobiomeTrials← Back to trialsNCT07890324
A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-12Est. Completion: 2027-08
Enrollment target: 96 participants Locations- National Cancer Center/Cancer Hospital, Beijing, China
Other microbiome trials you might be interested in
Cachexia; CancerCachexiaCachexia-Anorexia SyndromeMetastatic Colorectal Cancer (CRC)Metastatic Non-small Cell Lung Cancer (NSCLC)Weight LossAnorexia
The purpose of the OLE study is to evaluate the long-term safety and tolerability of rilogrotug treatment in participant…
Multiple LocationsEst. completion Oct 2028
Advanced Pancreatic Ductal AdenocarcinomaCancer Anorexia-Cachexia Syndrome
Cancer anorexia-cachexia syndrome is a common and severe complication in patients with advanced cancer, with a particula…
Jinan, ChinaEst. completion Dec 30, 2027